Our Research
Study Title: Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Trial)
Study Setting/Site: The Makerere University Joint AIDS Program (MJAP), Mulago ISS Clinic in Kampala, Uganda
Overview:
This is a five-year project which started with a formative study in year one (November 2018)
Formative study objectives:
1. To assess the costs (direct and indirect) faced by clients to attend clinic visits
2. Conduct a pre-implementation assessment of 99DOTS using human-centered design (HCD) principles to refine the delivery strategy
3. To tailor and pilot test a preliminary decision aid focused on helping clients choose between receiving 3HP via DOT and SAT (via Knowledge, Attitudes and Practices, KAP, Interviews)
Readmore
